EK-8800 Ultrasound Bone Densitometer: A Global Solution for Radiation-Free Bone Health Screening

Ultrasound bone densitometers bound for clinics in Peru are undergoing final quality inspections.

On the production line of Jiangsu Yikang Medical Technology Co., Ltd., batches of ultrasound bone densitometers bound for clinics in Peru are undergoing final quality inspections. These devices will help doctors in Europe monitor patients' bone health more safely.
According to international market data, the global market for ultrasound bone density testing equipment is growing at an annual rate of 6.8%, with radiation-free and portable devices being particularly favored by primary medical institutions and physical examination centers.
Technical Advantages
The ultrasound bone densitometer developed by Jiangsu Yikang Medical Technology Co., Ltd. adopts advanced Quantitative Ultrasound (QUS) technology. It accurately assesses bone health by measuring the Speed of Sound (SOS) and Broadband Ultrasound Attenuation (BUA) of ultrasonic waves in bones.
Equipped with a dual-probe design, the device can conduct simultaneous tests on the radius and tibia to obtain more comprehensive bone data. Its innovative adaptive algorithm automatically adjusts parameters based on the bone characteristics of different populations, ensuring the consistency and accuracy of measurement results.
Compared with the traditional Dual-Energy X-ray Absorptiometry (DXA), Yikang's ultrasound bone densitometer is completely free of ionizing radiation, making it safe for use in children, pregnant women, and patients requiring frequent monitoring. Featuring an integrated and portable design, the device weighs less than 5 kilograms, suitable for movement between different consulting rooms or on-site free clinics.
Clinical Applications
Yikang's ultrasound bone densitometer is widely used in various clinical scenarios worldwide. In osteoporosis screening, the device can quickly assess fracture risk, with the calculation of T-scores and Z-scores complying with international standards for easy cross-population comparison by doctors.
For pediatric applications, the device is specially designed with a pediatric-specific mode and reference database, which can monitor children's bone development and evaluate the impact of nutritional deficiencies on bone health. Monitoring bone mineral loss in women during pregnancy and lactation is another important clinical application, and its radiation-free feature makes it an ideal choice for this sensitive group.
In the field of rehabilitation medicine, the device can be used to track the progress of fracture healing or evaluate the impact of various therapeutic interventions on bone health. Physical examination centers and community medical programs leverage its rapid screening capability for large-scale population bone health surveys.
International Certification and Support
Yikang's ultrasound bone densitometer has obtained the EU CE certification, complying with the requirements of the Medical Device Directive 93/42/EEC. The company's quality management system is certified to ISO 13485, ensuring that every link from product design to production meets international standards.
To meet the regulatory requirements of different countries, Yikang provides comprehensive technical document support, including clinical evaluation reports, biocompatibility test data, and electrical safety certifications. The device software supports a multilingual interface, which can be customized into English, Spanish, French, Arabic and other language versions according to customer needs.
A community medical center in Lyon, France, has completed more than 500 bone density screenings using Yikang's ultrasound bone densitometer to date. Dr. Lefèvre, Director of the medical center, said: "The device is easy to operate and fast in testing, making it particularly suitable for our high-throughput screening clinic."
At Silver Care Nursing Home, Yikang's devices are used for regular monitoring of the bone health of elderly residents. Masako Tanaka, the nursing supervisor, pointed out: "The radiation-free feature allows us to safely conduct quarterly examinations for residents and adjust nutrition and exercise plans in a timely manner."
A team of researchers in Djibouti compared Yikang's ultrasound bone densitometer with mainstream DXA devices. The study showed that the consistency between the two methods in screening osteoporosis risk reached 90.6%, affirming the value of the ultrasound method in primary screening.
Market Prospect
The global population aging continues to intensify, with the proportion of people over 65 years old expected to rise from 9.3% in 2020 to 16.0% in 2050. This trend directly drives the growing demand for osteoporosis screening and management.
The expansion of primary medical services creates new opportunities for portable medical devices. The "Primary Health Care Strengthening" strategy advocated by the World Health Organization encourages chronic disease screening at the community level, and lightweight and easy-to-operate testing devices are highly aligned with this direction.
Technological progress is also constantly expanding the application boundaries of ultrasound bone densitometers. The integration of artificial intelligence algorithms enables the device to provide personalized risk assessments, while cloud data platforms make telemedicine and cross-institutional data comparison possible.
An ultrasound bone densitometer bound for the Middle East is undergoing final Arabic system testing, with technicians carefully checking each operation interface. This device will soon be put into use at a women's health center in the United Arab Emirates, helping local doctors monitor bone changes in pregnant women more safely.
When technological innovation meets global health needs, medical devices are no longer just products, but bridges connecting health management across different regions and populations. Through this radiation-free ultrasound bone densitometer, Yikang Medical is redefining the possibilities of bone health screening worldwide.